New documents suggest that the National Institute of Health (NIH) owns half the key patent for Moderna’s controversial COVID vaccine and could collect half the royalties. In addition, four NIH scientists have filed their own patent application allowing them royalties as co-inventors. These rules are recipes for regulatory corruption.